OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

DeLLphi-305: Durvalumab + Tarlatamab Improves Survival in First-Line ES-SCLC

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines

Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health Resilience

Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1

Oncology News, Insights, Stories by OncoDaily

Fatima Maada Bio
OncoDaily Magazine

I Am Fatima’s Child 

VIRO 2026
Not To Miss

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1

ESMO
Not To Miss

ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Breast Cancer ADC Trials 2026: Critical PFS–OS Gap Revealed

ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research

Enrique Grande: Rethinking Bladder Preservation in Muscle-Invasive Bladder Cancer

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1

Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow

David Tuveson Appointed Executive Director of Duke Cancer Institute

Voices
Kimryn Rathmell

Kimryn Rathmell: Welcoming Dr. Liza Makowski to OSU Comprehensive Cancer Center

Hari Prakash: A Scoping Review of Design Strategies to Address Cancer Disparities

Solomon Rotimi: How Our Science is Contributing to Reducing the Burden of Prostate Cancer

Maria E. Lopez Garcia: Incredibly Proud to Contribute to the Launch of Young SIOP Voices

David Gandara on KALC Conference in Seoul Preceding WCLC

Manju George: Mississippi Launches MS80 By 2030 to Raise Colorectal Cancer Screening

Lazar Popovic: Choosing Optimal First-Line Immunotherapy for Metastatic RCC at VIRO 2026

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

European Course in Paediatric Radiology (ECPR) 2026 – Module 1: Musculoskeletal Imaging

European Society of Paediatric Radiology (ESPR)

17 Sep
Paediatric Radiology

ESPR 2027 – 60th Annual Meeting and 46th Postgraduate Course

European Society of Paediatric Radiology (ESPR)

07 Jun
ESPR 2027

European Course in Paediatric Radiology (ECPR) 2026 – Module 2

European Society of Paediatric Radiology (ESPR)

04 Nov
Paediatric Radiology

The ESTRO 2027 Congress

European Society for Radiotherapy and Oncology (ESTRO)

21 May
ESTRO 2027

CRIHM Festival 2026: A Celebration of Music, Community and Cancer Research

Cancer Research & Innovation Hub Malta (CRIHM)

24 Sep
CRIHM Festival 2026

Immune-oncology
Myeloid-Derived Suppressor Cells in Cancer: How MDSCs Block Immunotherapy

Myeloid-Derived Suppressor Cells in Cancer: How MDSCs Block Immunotherapy

Can 3D Ex Vivo Lymphoma Spheroids Predict Immunotherapy Response? 

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Etentamig and the Next Wave of Immune Engagers in Multiple Myeloma

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Gastrointestinal-Oncology
EMERALD-3

Phase 3 EMERALD-3 Trial: STRIDE ± Lenvatinib Plus TACE in Embolization-Eligible HCC

Why Gastric Cancer Spreads Across the Abdomen: The Biology of Peritoneal Metastasis

Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests

Hepatocellular Carcinoma and Viral Hepatitis: How HBV and HCV Drive Liver Cancer

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Breast-Oncology
SERENA-4

SERENA-4 Misses Its Primary Endpoint: What the First-Line Camizestrant Result Means for HR-Positive Breast Cancer

SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer

Breast Cancer ADC Trials 2026: Critical PFS–OS Gap Revealed

Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1

Anbenitamab Plus HB1801 Improves Pathologic Complete Response in HER2-Positive Early Breast Cancer

Breast Cancer Treatment Sequencing 2026: Powerful New Insights for Better Outcomes

Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer

Lung-Oncology
WCLC 2026

WCLC 2026 Opens in Seoul: Targeted Therapy Moves Earlier as SCLC Enters a New Therapeutic Era

DeLLphi-305: Durvalumab + Tarlatamab Improves Survival in First-Line ES-SCLC

Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

Targeted Therapy in Advanced NSCLC: From Driver Matching to Adaptive Precision Oncology

Durvalumab Plus Tarlatamab Improves Overall Survival in First-Line Extensive-Stage Small Cell Lung Cancer

Stage III NSCLC Management 2026: Powerful Advances Transforming Multimodal Care

OncoDaily TV
Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Not To Miss
Value Cube

New "Value Cube" Framework in Nature Medicine Seeks to Redefine Value in Global Oncology

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 2

Top 10 Cancer Research Grants Open This Fall

ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1

Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow

Agenus to Present 3-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026

OncoGrants
Sarcoma Foundation

Sarcoma Foundation of America Research Grants 2027

Translation of Technologies

NIH Academic–Industrial Partnerships for Translation of Technologies R01 Grant 2026

Independence K99/R00 Award

NCI Pathway to Independence K99/R00 Award 2026

CDMRP

CDMRP Breast Cancer Clinical Research Extension Award 2026

MD Young Investigator Award

MOASC Cary Presant, MD Young Investigator Award 2027

Excellence Mobility Programme

OECI Excellence Mobility Programme 2026 for Young Oncology Professionals

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Charbel Matar

Charbel Matar

Oncologists Location Washington, USA
Wafik El-Deiry

Wafik El-Deiry

Oncologists Location Providence, USA
Jalid Sehouli

Jalid Sehouli

Oncologists Location Berlin, Germany
Mounir Bachouchi

Mounir Bachouchi

Oncologists Location Rabat, Morocco
Hesham ElGhazaly

Hesham ElGhazaly

Oncologists Location Cairo, Egypt
Saima Alvi

Saima Alvi

Oncologists Location
Mary Gospodarowicz

Mary Gospodarowicz

Oncologists Location Toronto, Canada
Tung Nguyen

Tung Nguyen

Oncologists Location Hanoi, Vietnam

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Bibek Aryal

Bibek Aryal: Introducing the Value Cube for Global Oncology

Enrique Grande

Enrique Grande: Rethinking Bladder Preservation in Muscle-Invasive Bladder Cancer

Salman Punekar

Salman Punekar: Daraxonrasib Marks a New Era for RAS-Mutated Lung Cancer

Sacrococcygeal Teratomas

New Paper Alert: Multidisciplinary Management of Altman Type III Sacrococcygeal Teratomas in Benin

Jithma Abeykoon

Jithma Abeykoon: NGS Profiling Is Essential for All Rosai-Dorfman Disease Tumors

Jasmin Hundal

Jasmin Hundal: New Study Reveals Breast Cancer Disparities Among South Asian American Women

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts